Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098992309> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2098992309 endingPage "333" @default.
- W2098992309 startingPage "329" @default.
- W2098992309 abstract "Following approval in the EU in 2002 and the USA in 2003, an Intensive Safety Surveillance Scheme (IS(3) ) was initiated to educate prescribers on the appropriate use of miglustat for the treatment of type I Gaucher disease (GD1), and to actively solicit safety-relevant information. This report summarises data from all patients enrolled in IS(3) between its initiation in 2003 and its closure in October 2012.The IS(3) was a prospective observational drug registry with a secure internet-based data capture system. All patients receiving miglustat at participating sites received standard medical care according to routine medical practice. Data on patient and disease characteristics were collected at patient enrolment, subsequent follow-up visits and treatment discontinuation (if applicable). Data were summarised using descriptive statistics.During the 9 years of IS(3) , 407 patients were enrolled at 111 sites across 15 European countries. Approximately half (n = 202) had GD1, and half had other diseases (mainly Niemann-Pick disease type C (NP-C), for which miglustat was approved in Europe in 2009). In total, 368 patients had data from at least one follow-up visit, 192 of whom had GD1. IS(3) provided data from 798 patient-years exposure to miglustat. Safety-relevant data were consistent with earlier published 5-year findings from IS(3) , the safety profile reported for miglustat in GD1 clinical trials and other published information on GD1 manifestations.Overall, the results of this long-term safety surveillance programme were in line with the well-known, documented safety profile of miglustat." @default.
- W2098992309 created "2016-06-24" @default.
- W2098992309 creator A5002294585 @default.
- W2098992309 creator A5007277308 @default.
- W2098992309 creator A5046731360 @default.
- W2098992309 creator A5049352494 @default.
- W2098992309 creator A5067439902 @default.
- W2098992309 creator A5080528552 @default.
- W2098992309 date "2015-02-05" @default.
- W2098992309 modified "2023-10-06" @default.
- W2098992309 title "Results from a 9-year Intensive Safety Surveillance Scheme (IS<sup>3</sup> ) in miglustat (Zavesca<sup>®</sup> )-treated patients" @default.
- W2098992309 cites W1982347529 @default.
- W2098992309 cites W2012506180 @default.
- W2098992309 cites W2064154424 @default.
- W2098992309 cites W2065186120 @default.
- W2098992309 cites W2087709622 @default.
- W2098992309 cites W2093722439 @default.
- W2098992309 cites W2124185054 @default.
- W2098992309 cites W2125281037 @default.
- W2098992309 cites W2132911597 @default.
- W2098992309 cites W2133958457 @default.
- W2098992309 cites W2135424735 @default.
- W2098992309 cites W2138034498 @default.
- W2098992309 cites W2171872962 @default.
- W2098992309 doi "https://doi.org/10.1002/pds.3760" @default.
- W2098992309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25656910" @default.
- W2098992309 hasPublicationYear "2015" @default.
- W2098992309 type Work @default.
- W2098992309 sameAs 2098992309 @default.
- W2098992309 citedByCount "13" @default.
- W2098992309 countsByYear W20989923092016 @default.
- W2098992309 countsByYear W20989923092017 @default.
- W2098992309 countsByYear W20989923092018 @default.
- W2098992309 countsByYear W20989923092020 @default.
- W2098992309 countsByYear W20989923092022 @default.
- W2098992309 crossrefType "journal-article" @default.
- W2098992309 hasAuthorship W2098992309A5002294585 @default.
- W2098992309 hasAuthorship W2098992309A5007277308 @default.
- W2098992309 hasAuthorship W2098992309A5046731360 @default.
- W2098992309 hasAuthorship W2098992309A5049352494 @default.
- W2098992309 hasAuthorship W2098992309A5067439902 @default.
- W2098992309 hasAuthorship W2098992309A5080528552 @default.
- W2098992309 hasConcept C126322002 @default.
- W2098992309 hasConcept C187212893 @default.
- W2098992309 hasConcept C194828623 @default.
- W2098992309 hasConcept C195910791 @default.
- W2098992309 hasConcept C23131810 @default.
- W2098992309 hasConcept C2778715236 @default.
- W2098992309 hasConcept C512399662 @default.
- W2098992309 hasConcept C535046627 @default.
- W2098992309 hasConcept C71924100 @default.
- W2098992309 hasConceptScore W2098992309C126322002 @default.
- W2098992309 hasConceptScore W2098992309C187212893 @default.
- W2098992309 hasConceptScore W2098992309C194828623 @default.
- W2098992309 hasConceptScore W2098992309C195910791 @default.
- W2098992309 hasConceptScore W2098992309C23131810 @default.
- W2098992309 hasConceptScore W2098992309C2778715236 @default.
- W2098992309 hasConceptScore W2098992309C512399662 @default.
- W2098992309 hasConceptScore W2098992309C535046627 @default.
- W2098992309 hasConceptScore W2098992309C71924100 @default.
- W2098992309 hasFunder F4320338282 @default.
- W2098992309 hasIssue "3" @default.
- W2098992309 hasLocation W20989923091 @default.
- W2098992309 hasLocation W20989923092 @default.
- W2098992309 hasOpenAccess W2098992309 @default.
- W2098992309 hasPrimaryLocation W20989923091 @default.
- W2098992309 hasRelatedWork W2014238892 @default.
- W2098992309 hasRelatedWork W2060361110 @default.
- W2098992309 hasRelatedWork W2360693916 @default.
- W2098992309 hasRelatedWork W2415484199 @default.
- W2098992309 hasRelatedWork W2419505618 @default.
- W2098992309 hasRelatedWork W2580334472 @default.
- W2098992309 hasRelatedWork W3121096891 @default.
- W2098992309 hasRelatedWork W4254834665 @default.
- W2098992309 hasRelatedWork W4320086256 @default.
- W2098992309 hasRelatedWork W2464739384 @default.
- W2098992309 hasVolume "24" @default.
- W2098992309 isParatext "false" @default.
- W2098992309 isRetracted "false" @default.
- W2098992309 magId "2098992309" @default.
- W2098992309 workType "article" @default.